⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6552562 | 0.82 | EPHX1 (0.31) | — | |
| SCHEMBL2454575 | 0.79 | EPHX1 (0.36) | — | |
| SCHEMBL6606387 | 0.77 | EPHX1 (0.39) | — | |
| SCHEMBL28169619 | 0.74 | — | — | |
| SCHEMBL6686763 | 0.73 | — | — | |
| SCHEMBL28408544 | 0.73 | F2 (0.31) | — | |
| SCHEMBL9027632 | 0.73 | CA2 (0.36) | — | |
| SCHEMBL2904316 | 0.72 | CA1 (0.38) | — | |
| SCHEMBL9027630 | 0.71 | — | — | |
| SCHEMBL5155693 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023142618-A1 | SYNTHESIS METHOD FOR EUPHORBIA DITERPENOID PEPLUANOL A | 浙江大学杭州国际科创中心 | 2023-08-03 | — | — | WO | claimed |
| JP-5345794-A | — | — | None | — | — | JP | disclosed |
| WO-2022256490-A9 | IMPROVED SYNTHESIS OF PHOSPHORAMIDATES FOR THE TREATMENT OF HEPATITIS B VIRUS | Antios Therapeutics, Inc. (US) | 2023-08-17 | — | — | WO | disclosed |
| US-8314246-B2 | Catalytic reactions involving alkenes | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2012-11-20 | — | — | US | disclosed |
| US-20090216025-A1 | Catalytic reactions involving alkenes | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2009-08-27 | — | — | US | disclosed |
| WO-2007027752-A1 | CATALYTIC REACTIONS INVOLVING ALKENES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2007-03-08 | — | — | WO | disclosed |
| EP-1749001-A1 | 3-PIPERIDINYLISOCHROMAN-5-OLS AS DOPAMINE AGONISTS | Aventis Pharmaceuticals, Inc. (US) | 2007-02-07 | — | — | EP | disclosed |
| US-7173137-B2 | Epothilone analogs | THE SCRIPPS RESEARCH INSTITUTE (US) | 2007-02-06 | — | — | US | disclosed |
| WO-2005111025-A1 | 3-PIPERIDINYLISOCHROMAN-5-OLS AS DOPAMINE AGONISTS | AVENTIS PHARMACEUTICALS INC. (US) | 2005-11-24 | — | — | WO | disclosed |
| US-20040127432-A1 | Epothilone analogs | THE SCRIPPS RESEARCH INSTITUTE | 2004-07-01 | — | — | US | disclosed |
| WO-1995009175-A1 | RING-EXPANDED NUCLEOSIDES AND NUCLEOTIDES | BURNS BARRY (US) | 1995-04-06 | — | — | WO | disclosed |
| WO-1995008557-A1 | NOVEL OLIGOSACCHARIDE-CONTAINING 14-AMINOSTEROID COMPOUNDS AND NOVEL DIASTEREOSELECTIVE AMINOSTEROID PROCESS CHEMISTRY | THE PROCTER & GAMBLE COMPANY (US) | 1995-03-30 | — | — | WO | disclosed |
| EP-0642345-A1 | HALICHONDRINS AND RELATED COMPOUNDS | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1995-03-15 | — | — | EP | disclosed |
| JP-H05345794-A | PRODUCTION OF GLYCOSYLANTHRACYCLINONES | BEHRINGWERKE AG | 1993-12-27 | — | — | JP | disclosed |
| EP-0562009-A4 | ENANTIOMERICALLY PURE -G(B)-D-(-)-DIOXOLANE-NUCLEOSIDES | — | 1993-11-24 | — | — | EP | disclosed |
| EP-0562009-A1 | ENANTIOMERICALLY PURE $g(b)-D-(-)-DIOXOLANE-NUCLEOSIDES | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1993-09-29 | — | — | EP | disclosed |
| EP-0560794-A1 | SUBSTITUTED 1,3-OXATHIOLANES AND SUBSTITUTED 1,3-DITHIOLANES WITH ANTIVIRAL PROPERTIES. | IAF BIOCHEM INT (CA) | 1993-09-22 | — | — | EP | disclosed |
| WO-1993017690-A1 | HALICHONDRINS AND RELATED COMPOUNDS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1993-09-16 | — | — | WO | disclosed |
| WO-1993000908-A1 | ELAM-1 RECEPTOR LIGANDS AS DIAGNOSTIC COMPOUNDS | ANTISOMA LIMITED (GB) | 1993-01-21 | — | — | WO | disclosed |
| WO-1992010497-A1 | ENANTIOMERICALLY PURE β-D-(-)-DIOXOLANE-NUCLEOSIDES | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1992-06-25 | — | — | WO | disclosed |